Blastocysts Re-analysis after Cleavage Stage Biopsy with 24 Chromosome Array Comparative Genomic Hybridization (CGH). How Reliable is the PGS Report?

Richard Buyalos,Lian Liu,Ashim Kumar,Felicia Wetherby,Raul Leony,Man Li
DOI: https://doi.org/10.1016/j.fertnstert.2013.01.065
IF: 6.7
2013-01-01
Fertility and Sterility
Abstract:Objective(s)With improvements in culture conditions, blastocyst development rates have increased. It is clear that some embryos diagnosed as aneuploid from cleavage stage biopsy will progress to blastocysts following extended culture. The objective of this prospective study was to determine the accuracy of the diagnosis of aneuploidy after cleavage stage embryo biopsy using CGH with confirmatory re-biopsy at the blastocyst stage.DesignProspective Analysis of re-biopsied blastocysts with the diagnosis of aneuploidy using microarray CGH after cleavage stage biopsy.Materials and Method(s)From April to Nov 2012, 118 cleavage stage embryos were biopsied from 19 poor prognosis patients. Euploid embryos were transferred on D5 or vitrified. Blastocysts with the diagnosis of aneuploidy from cleavage stage biopsy were re-biopsied and retested.Result(s)20 of 22 (91%) of euploid cleavage stage embryos that were biopsied developed to the blastocyst stage. 11 patients had at least one euploid embryo available for transfer (ET). Two patients had only a single morula stage embryo available for ET. 7 of 11 patients with ET have ongoing pregnancies. 96 embryos were diagnosed as aneuploid after cleavage stage biopsy and analysis with CGH. Of these 96 embryos, 51 developed to the blastocyst stage on D5/6 and were re-biopsied and analyzed. 44 of 51 embryos (86%) confirmed the diagnosis of aneuploidy. 1 analysis was nondiagnostic. 5 of 51 (9.8%) were euploid at the time of repeat biopsy and re-analysis. A single chromosome abnormality had a confirmation rate of 92.9% (26/28). Aneuploid embryos with 2 or more chromosomal abnormalities had a confirmation rate of 81.8% (18/22) after re-biopsy and analysis.Conclusion(s)PGS may enable improved embryo selection for ET.10% of blastocysts with the diagnosis of aneuploidy after cleavage stage biopsy were found to be euploid after trophectoderm biopsy and re-analysis by CGH.We postulate that the discordance between cleavage stage and trophectoderm biopsy results with CGH may be attributed to either mosaicism in individual blastomeres in the cleavage stage embryo or artifact generated in CGH analysis. Objective(s)With improvements in culture conditions, blastocyst development rates have increased. It is clear that some embryos diagnosed as aneuploid from cleavage stage biopsy will progress to blastocysts following extended culture. The objective of this prospective study was to determine the accuracy of the diagnosis of aneuploidy after cleavage stage embryo biopsy using CGH with confirmatory re-biopsy at the blastocyst stage. With improvements in culture conditions, blastocyst development rates have increased. It is clear that some embryos diagnosed as aneuploid from cleavage stage biopsy will progress to blastocysts following extended culture. The objective of this prospective study was to determine the accuracy of the diagnosis of aneuploidy after cleavage stage embryo biopsy using CGH with confirmatory re-biopsy at the blastocyst stage. DesignProspective Analysis of re-biopsied blastocysts with the diagnosis of aneuploidy using microarray CGH after cleavage stage biopsy. Prospective Analysis of re-biopsied blastocysts with the diagnosis of aneuploidy using microarray CGH after cleavage stage biopsy. Materials and Method(s)From April to Nov 2012, 118 cleavage stage embryos were biopsied from 19 poor prognosis patients. Euploid embryos were transferred on D5 or vitrified. Blastocysts with the diagnosis of aneuploidy from cleavage stage biopsy were re-biopsied and retested. From April to Nov 2012, 118 cleavage stage embryos were biopsied from 19 poor prognosis patients. Euploid embryos were transferred on D5 or vitrified. Blastocysts with the diagnosis of aneuploidy from cleavage stage biopsy were re-biopsied and retested. Result(s)20 of 22 (91%) of euploid cleavage stage embryos that were biopsied developed to the blastocyst stage. 11 patients had at least one euploid embryo available for transfer (ET). Two patients had only a single morula stage embryo available for ET. 7 of 11 patients with ET have ongoing pregnancies. 96 embryos were diagnosed as aneuploid after cleavage stage biopsy and analysis with CGH. Of these 96 embryos, 51 developed to the blastocyst stage on D5/6 and were re-biopsied and analyzed. 44 of 51 embryos (86%) confirmed the diagnosis of aneuploidy. 1 analysis was nondiagnostic. 5 of 51 (9.8%) were euploid at the time of repeat biopsy and re-analysis. A single chromosome abnormality had a confirmation rate of 92.9% (26/28). Aneuploid embryos with 2 or more chromosomal abnormalities had a confirmation rate of 81.8% (18/22) after re-biopsy and analysis. 20 of 22 (91%) of euploid cleavage stage embryos that were biopsied developed to the blastocyst stage. 11 patients had at least one euploid embryo available for transfer (ET). Two patients had only a single morula stage embryo available for ET. 7 of 11 patients with ET have ongoing pregnancies. 96 embryos were diagnosed as aneuploid after cleavage stage biopsy and analysis with CGH. Of these 96 embryos, 51 developed to the blastocyst stage on D5/6 and were re-biopsied and analyzed. 44 of 51 embryos (86%) confirmed the diagnosis of aneuploidy. 1 analysis was nondiagnostic. 5 of 51 (9.8%) were euploid at the time of repeat biopsy and re-analysis. A single chromosome abnormality had a confirmation rate of 92.9% (26/28). Aneuploid embryos with 2 or more chromosomal abnormalities had a confirmation rate of 81.8% (18/22) after re-biopsy and analysis. Conclusion(s)PGS may enable improved embryo selection for ET.10% of blastocysts with the diagnosis of aneuploidy after cleavage stage biopsy were found to be euploid after trophectoderm biopsy and re-analysis by CGH.We postulate that the discordance between cleavage stage and trophectoderm biopsy results with CGH may be attributed to either mosaicism in individual blastomeres in the cleavage stage embryo or artifact generated in CGH analysis. PGS may enable improved embryo selection for ET.
What problem does this paper attempt to address?